MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.

Mol Med Rep · 2017 · PMC5865862 · PMID 28944826

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

NSCLC includes large cell carcinoma, squamous cell carcinoma and adenocarcinoma that additionally present an increasing trend and incidence rate ( 8 – 10 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.